299 related articles for article (PubMed ID: 30079135)
21. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
[No Abstract] [Full Text] [Related]
22. Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study.
Morishita A; Tani J; Nomura T; Takuma K; Nakahara M; Oura K; Tadokoro T; Fujita K; Shi T; Yamana H; Matsui T; Takata T; Sanomura T; Nishiyama Y; Himoto T; Tomonari T; Moriya A; Senoo T; Takaguchi K; Masaki T
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572832
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic Changes on Cone-Beam Computed Tomography during Balloon-Occluded Transcatheter Arterial Chemoembolization Using Miriplatin for Hepatocellular Carcinoma: A Preliminary Study.
Ishikawa T; Imai M; Owaki T; Sato H; Nozawa Y; Sano T; Iwanaga A; Seki K; Honma T; Yoshida T; Kudo M
Dig Dis; 2017; 35(6):598-601. PubMed ID: 29040993
[TBL] [Abstract][Full Text] [Related]
24. Improved survival with double platinum therapy transcatheter arterial infusion using cisplatin and transcatheter arterial chemoembolization using miriplatin for BCLC-B hepatocellular carcinoma.
Ishikawa T; Abe S; Watanabe T; Nozawa Y; Sano T; Iwanaga A; Seki K; Honma T; Yoshida T
Mol Clin Oncol; 2016 Nov; 5(5):511-516. PubMed ID: 27882236
[TBL] [Abstract][Full Text] [Related]
25. Surgical and Locoregional Therapy of HCC: TACE.
Tsurusaki M; Murakami T
Liver Cancer; 2015 Sep; 4(3):165-75. PubMed ID: 26675172
[TBL] [Abstract][Full Text] [Related]
26. Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization.
Kobayashi S; Tajiri K; Murayama A; Entani T; Futsukaichi Y; Nagata K; Takahashi K; Yasuda I
J Hepatocell Carcinoma; 2020; 7():181-189. PubMed ID: 33117752
[TBL] [Abstract][Full Text] [Related]
27. Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in the Downstaging of Intermediate-Stage Hepatocellular Carcinoma (HCC) in Patients With a Child-Pugh Score of 8-9.
Minici R; Ammendola M; Manti F; Siciliano MA; Minici M; Komaei I; Currò G; Laganà D
Front Pharmacol; 2021; 12():634087. PubMed ID: 33897422
[TBL] [Abstract][Full Text] [Related]
28. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art.
Facciorusso A
World J Gastroenterol; 2018 Jan; 24(2):161-169. PubMed ID: 29375202
[TBL] [Abstract][Full Text] [Related]
29. Temporal variations in stump pressure and assessment of images obtained from cone-beam computed tomography during balloon-occluded transarterial chemoembolization.
Kakuta A; Shibutani K; Ono S; Miura H; Tsushima F; Kakehata S; Basaki K; Fujita H; Seino H; Fujita T; Takai Y
Hepatol Res; 2016 Mar; 46(5):468-76. PubMed ID: 26333025
[TBL] [Abstract][Full Text] [Related]
30. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence.
Raoul JL; Forner A; Bolondi L; Cheung TT; Kloeckner R; de Baere T
Cancer Treat Rev; 2019 Jan; 72():28-36. PubMed ID: 30447470
[TBL] [Abstract][Full Text] [Related]
31. Transarterial chemoembolization (TACE) in the management of hepatocellular carcinoma: Results of a French national survey on current practices.
Fohlen A; Tasu JP; Kobeiter H; Bartoli JM; Pelage JP; Guiu B
Diagn Interv Imaging; 2018 Sep; 99(9):527-535. PubMed ID: 29609903
[TBL] [Abstract][Full Text] [Related]
32. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
33. Sulfamethazine-based pH-sensitive hydrogels with potential application for transcatheter arterial chemoembolization therapy.
Lym JS; Nguyen QV; Ahn da W; Huynh CT; Jae HJ; Kim YI; Lee DS
Acta Biomater; 2016 Sep; 41():253-63. PubMed ID: 27184404
[TBL] [Abstract][Full Text] [Related]
34. A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma.
Yodono H; Matsuo K; Shinohara A
Anticancer Drugs; 2011 Mar; 22(3):277-82. PubMed ID: 21360850
[TBL] [Abstract][Full Text] [Related]
35. In Vitro Model for Simulating Drug Delivery during Balloon-Occluded Transarterial Chemoembolization.
Aramburu J; Antón R; Fukamizu J; Nozawa D; Takahashi M; Ozaki K; Ramos JC; Sangro B; Bilbao JI; Tomita K; Matsumoto T; Hasebe T
Biology (Basel); 2021 Dec; 10(12):. PubMed ID: 34943256
[TBL] [Abstract][Full Text] [Related]
36. Numerical zero-dimensional hepatic artery hemodynamics model for balloon-occluded transarterial chemoembolization.
Aramburu J; Antón R; Rivas A; Ramos JC; Larraona GS; Sangro B; Bilbao JI
Int J Numer Method Biomed Eng; 2018 Jul; 34(7):e2983. PubMed ID: 29575739
[TBL] [Abstract][Full Text] [Related]
37. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma.
Nam HC; Jang B; Song MJ
World J Gastroenterol; 2016 Oct; 22(40):8853-8861. PubMed ID: 27833376
[TBL] [Abstract][Full Text] [Related]
38. Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching.
Golfieri R; Bezzi M; Verset G; Fucilli F; Mosconi C; Cappelli A; Paccapelo A; Lucatelli P; Magand N; Rode A; De Baere T
Liver Cancer; 2021 Sep; 10(5):522-534. PubMed ID: 34721513
[TBL] [Abstract][Full Text] [Related]
39. Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma.
Liu KC; Lv WF; Lu D; Hou CL; Xie J; Lu YH; Cao QS; Tan YL; Zhang YZ; Liu J
Cancer Manag Res; 2021; 13():7973-7980. PubMed ID: 34703317
[TBL] [Abstract][Full Text] [Related]
40. The Degree of Lipiodol Accumulation Can Be an Indicator of Successful Treatment for Unresectable Hepatocellular Carcinoma (HCC) Patients - in the Case of Transcatheter Arterial Chemoembolization (TACE) and External Beam Radiotherapy (EBRT).
Yang P; Zeng ZC; Wang BL; Zhang JY; Fan J; Zhou J; Hu Y
J Cancer; 2016; 7(11):1413-20. PubMed ID: 27471557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
